For pharma and biotech companies today, traditional reliance on multiple vendors to manage different aspects of drug development may compound challenging market dynamics, such as escalating ...

TUCSON, Ariz., June 18, 2025 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today a $250,000 grant award aimed at developing a novel treatment ...

Lyndra Therapeutics and Thermo Fisher Scientific have entered a strategic partnership to develop Lyndra's long-acting oral therapies for conditions such as schizophrenia and bipolar disorder. Lyndra ...

AUSTIN, Texas, June 4, 2024 /PRNewswire/ — The Foundation for Angelman Syndrome Therapeutics (FAST) announced the establishment of an associated drug development accelerator called AS 2 Bio Inc. The ...

The new venture is backed by Biovance Capital, Torrey Pines Investment, and OrbiMed. Mondego Bio is advancing a portfolio of first- and best-in-class PTPN2 inhibitors designed to transform cancer ...

There are several bottlenecks in the drug development process, such as working out the mode of action of a new therapeutic and its molecular targets and identifying off-target effects. This work ...

It’s no secret. Drug development and clinical research continue to get more complex. And with that increasing complexity come rising costs and the risk of delays that can slow the delivery of critical ...

Thermo Fisher Scientific Inc., the world leader in serving science, will showcase its latest flexible solutions to help boost efficiency and scale in biopharmaceutical manufacturing at every stage of ...

Hackensack Meridian Health and Rutgers University have landed a multi-million-dollar grant from the National Institutes of Health to fast-track potential new drugs for antibiotic-resistant infections, ...

Ready to expand the possibilities of biomarker science? The Simoa® Accelerator Laboratory is a full-service center for biopharmaceutical research. The Accelerator Lab provides exploratory protein ...